Red blood cell transfusion therapy.
This article describes the characteristics of alloantibodies associated with accelerated in vivo red cell destruction, pretransfusion tests performed to detect these antibodies, and the resolution of the incompatible crossmatch. Current transfusion practices, the indications for, and the complications of red cell transfusions are discussed.
D000163:Acquired Immunodeficiency Syndrome / Q000635:transmission; D000707:Anaphylaxis / Q000209:etiology; D001771:Blood Banks; D001803:Blood Transfusion; D003586:Cytomegalovirus Infections / Q000635:transmission; D017707:Erythrocyte Transfusion; D006461:Hemolysis; D006505:Hepatitis / Q000635:transmission; D006801:Humans; D007518:Isoantibodies / Q000276:immunology; D008288:Malaria / Q000635:transmission; D008297:Male; D011693:Purpura / Q000209:etiology; D018805:Sepsis / Q000209:etiology; D013587:Syphilis / Q000635:transmission; D065227:Transfusion Reaction; D014181:Transplantation Immunology
D007518:Isoantibodies